These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26680439)

  • 1. Persons in correctional facilities in Canada: A key population for hepatitis C prevention and control.
    Kouyoumdjian FG; McIsaac KE
    Can J Public Health; 2015 Oct; 106(6):e454-6. PubMed ID: 26680439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seropositivity of hepatitis C in prison inmates of Pakistan--a cross sectional study in prisons of Sindh.
    Gorar ZA; Zulfikar I
    J Pak Med Assoc; 2010 Jun; 60(6):476-9. PubMed ID: 20527648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
    Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities to address the hepatitis C epidemic in the correctional setting.
    Boutwell AE; Allen SA; Rich JD
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and the correctional population.
    Reindollar RW
    Am J Med; 1999 Dec; 107(6B):100S-103S. PubMed ID: 10653468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of hepatitis B and C among prison population in Croatia].
    Burek V; Horvat J; Susić E; Mikulić R
    Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and prevention of hepatitis C in Australian prisons.
    Dolan K
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):68-9. PubMed ID: 11833205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.
    Macalino GE; Vlahov D; Sanford-Colby S; Patel S; Sabin K; Salas C; Rich JD
    Am J Public Health; 2004 Jul; 94(7):1218-23. PubMed ID: 15226146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clean switch: the case for prison needle and syringe programs.
    Chu S
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):5-19. PubMed ID: 20225504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention.
    Weinbaum CM; Sabin KM; Santibanez SS
    AIDS; 2005 Oct; 19 Suppl 3():S41-6. PubMed ID: 16251827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework for management of hepatitis C in prisons.
    Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
    Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus transmission in the prison/inmate population.
    Skoretz S; Zaniewski G; Goedhuis NJ
    Can Commun Dis Rep; 2004 Aug; 30(16):141-8. PubMed ID: 15352686
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.
    Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L
    Ann Epidemiol; 2016 Aug; 26(8):570-578.e2. PubMed ID: 27480479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Kamarulzaman A; Reid SE; Schwitters A; Wiessing L; El-Bassel N; Dolan K; Moazen B; Wirtz AL; Verster A; Altice FL
    Lancet; 2016 Sep; 388(10049):1115-1126. PubMed ID: 27427456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
    Poulin C; Courtemanche Y; Serhir B; Alary M
    Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prisons and HCV: a review and a report on an experience in New South Wales Australia.
    Batey RG; Jones T; McAllister C
    Int J Prison Health; 2008; 4(3):156-63. PubMed ID: 18698530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.
    Varan AK; Mercer DW; Stein MS; Spaulding AC
    Public Health Rep; 2014; 129(2):187-95. PubMed ID: 24587554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.
    Hammett TM; Harmon MP; Rhodes W
    Am J Public Health; 2002 Nov; 92(11):1789-94. PubMed ID: 12406810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a Delphi process to define priorities for prison health research in Canada.
    Kouyoumdjian FG; Schuler A; McIsaac KE; Pivnick L; Matheson FI; Brown G; Kiefer L; Silva D; Hwang SW
    BMJ Open; 2016 Jan; 6(1):e010125. PubMed ID: 26769790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.